These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30257691)

  • 1. Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice.
    Rossi GA; Bessler W; Ballarini S; Pasquali C
    Ital J Pediatr; 2018 Sep; 44(1):112. PubMed ID: 30257691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
    Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
    Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection.
    Hedlund M; Aschenbrenner LM; Jensen K; Larson JL; Fang F
    J Infect Dis; 2010 Apr; 201(7):1007-15. PubMed ID: 20170378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3.
    Speshock JL; Doyon-Reale N; Rabah R; Neely MN; Roberts PC
    Infect Immun; 2007 Jun; 75(6):3102-11. PubMed ID: 17403870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.
    Chaussee MS; Sandbulte HR; Schuneman MJ; Depaula FP; Addengast LA; Schlenker EH; Huber VC
    Vaccine; 2011 May; 29(21):3773-81. PubMed ID: 21440037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae Coinfection.
    Roberts S; Salmon SL; Steiner DJ; Williams CM; Metzger DW; Furuya Y
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.
    Kash JC; Walters KA; Davis AS; Sandouk A; Schwartzman LM; Jagger BW; Chertow DS; Li Q; Kuestner RE; Ozinsky A; Taubenberger JK
    mBio; 2011; 2(5):. PubMed ID: 21933918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.
    Tong HH; Lambert G; Li YX; Thurman JM; Stahl GL; Douthitt K; Clancy C; He Y; Bowman AS
    PLoS One; 2014; 9(4):e95160. PubMed ID: 24740152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progranulin Decreases Susceptibility to
    Wang X; Yuan J; Wang H; Gan N; Zhang Q; Liu B; Wang J; Shu Z; Rao L; Gou X; Zhang H; Yin Y; Zhang X
    J Immunol; 2019 Oct; 203(8):2171-2182. PubMed ID: 31519865
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection.
    Barthelemy A; Ivanov S; Fontaine J; Soulard D; Bouabe H; Paget C; Faveeuw C; Trottein F
    Mucosal Immunol; 2017 Mar; 10(2):460-469. PubMed ID: 27220813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
    Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
    J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection.
    Ellis GT; Davidson S; Crotta S; Branzk N; Papayannopoulos V; Wack A
    EMBO Rep; 2015 Sep; 16(9):1203-18. PubMed ID: 26265006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response.
    Blevins LK; Wren JT; Holbrook BC; Hayward SL; Swords WE; Parks GD; Alexander-Miller MA
    J Immunol; 2014 Nov; 193(10):5076-87. PubMed ID: 25311807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection.
    Katsura H; Piao Z; Iwatsuki-Horimoto K; Akeda Y; Watanabe S; Horimoto T; Oishi K; Kawaoka Y
    J Virol; 2014 Nov; 88(22):13410-7. PubMed ID: 25210171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased susceptibility for superinfection with Streptococcus pneumoniae during influenza virus infection is not caused by TLR7-mediated lymphopenia.
    Stegemann S; Dahlberg S; Kröger A; Gereke M; Bruder D; Henriques-Normark B; Gunzer M
    PLoS One; 2009; 4(3):e4840. PubMed ID: 19290047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Pneumococcal NanC in the Severe Disease of
    Dutta A; Chen YY; Chen TC; Chang CS; Huang YL; Chen TA; Lin YC; Lin CY; Hsieh YC; Huang CT
    Immunohorizons; 2021 Apr; 5(4):210-218. PubMed ID: 33911017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections.
    Ghoneim HE; Thomas PG; McCullers JA
    J Immunol; 2013 Aug; 191(3):1250-9. PubMed ID: 23804714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo study on the immunomodulating effects of OM-85 BV on survival, inflammatory cell recruitment and bacterial clearance in Klebsiella pneumonia.
    Broug-Holub E; Kraal G
    Int J Immunopharmacol; 1997; 19(9-10):559-64. PubMed ID: 9637354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses.
    Damjanovic D; Lai R; Jeyanathan M; Hogaboam CM; Xing Z
    Am J Pathol; 2013 Sep; 183(3):868-80. PubMed ID: 23831294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.